Neuronetics reported a Q3 2025 EPS of -$0.13, missing estimates by 18.18%.The company's revenue was $37.3 million, slightly below expectations but showing significant year-over-year growth.Despite negative earnings, Neuronetics has a strong liquidity position with a current ratio of 2.02.Neuronetics, Inc. (NASDAQ: STIM) operates in the medical instruments industry, focusing on innovative solutions for mental health. The company recently reported its third-quarter earnings for 2025, revealing an earnings per ...